➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 4,978,772

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 4,978,772
Title: Utilization of otilonium bromide (DCI) for topical application in the gastroinstestinal tract and related pharmaceutical formulation appropriate for such use
Abstract:Use of bromure d\'otilonium, that it otilonii bromidum, for local applications in the gastrointestinal tract of the digestive system and related pharmaceutical formulation appropriate for such use, to obtain the arrest of the motility of the gastrointestinal tract in order to allow endoscopic manoeuvers for diagnostic and therapeutic purposes.
Inventor(s): Casini; Alessandro (Florence, IT), Parti; Sandro (Valdarno, IT), Bucci; Paolo (Montevarchi, IT)
Assignee: A. Menarini S.A.S. (Florence, IT)
Application Number:07/117,751
Patent Claims:see list of patent claims

Details for Patent 4,978,772

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live For Injection 125123 2006-05-25 ⤷  Try it Free 2007-12-18
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.